USD 2.08
(0.48%)
Year | Net Debt | Net Debt Growth |
---|---|---|
2023 | -109.6 Million USD | 16.12% |
2022 | -130.66 Million USD | 66.93% |
2021 | -395.15 Million USD | -6160.31% |
2020 | -6.31 Million USD | 92.99% |
2019 | -90 Million USD | 58.06% |
2018 | -214.57 Million USD | 0.0% |
Year | Net Debt | Net Debt Growth |
---|---|---|
2024 Q3 | -72.72 Million USD | 9.99% |
2024 Q1 | -88.31 Million USD | 19.43% |
2024 Q2 | -78.15 Million USD | 11.5% |
2023 Q2 | -138.1 Million USD | 15.98% |
2023 FY | -109.6 Million USD | 16.12% |
2023 Q1 | -164.36 Million USD | -25.79% |
2023 Q4 | -109.6 Million USD | 13.42% |
2023 Q3 | -126.59 Million USD | 8.33% |
2022 Q2 | -278.63 Million USD | 15.11% |
2022 Q1 | -328.21 Million USD | 16.94% |
2022 FY | -130.66 Million USD | 66.93% |
2022 Q4 | -130.66 Million USD | 19.0% |
2022 Q3 | -161.32 Million USD | 42.1% |
2021 FY | -395.15 Million USD | -6160.31% |
2021 Q1 | -18.85 Million USD | -198.64% |
2021 Q4 | -395.15 Million USD | -157.72% |
2021 Q3 | -153.32 Million USD | -682.08% |
2021 Q2 | -19.6 Million USD | -4.01% |
2020 FY | -6.31 Million USD | 92.99% |
2020 Q4 | -6.31 Million USD | 76.0% |
2020 Q3 | -26.3 Million USD | 0.0% |
2020 Q2 | - USD | -100.0% |
2020 Q1 | 90 Million USD | 200.0% |
2019 Q4 | -90 Million USD | 0.0% |
2019 FY | -90 Million USD | 58.06% |
2018 FY | -214.57 Million USD | 0.0% |
Name | Net Debt | Net Debt Difference |
---|---|---|
Abbott Laboratories | 8.97 Billion USD | 101.221% |
Allurion Technologies Inc. | 3.82 Million USD | 2969.346% |
Artivion, Inc. | 300.4 Million USD | 136.488% |
Avanos Medical, Inc. | 121.4 Million USD | 190.287% |
Butterfly Network, Inc. | -109.6 Million USD | -0.0% |
Bio-Rad Laboratories, Inc. | 1 Billion USD | 110.94% |
Boston Scientific Corporation | 8.62 Billion USD | 101.271% |
CONMED Corporation | 966.95 Million USD | 111.335% |
Edwards Lifesciences Corporation | -449.1 Million USD | 75.594% |
Paragon 28, Inc. | 36.39 Million USD | 401.198% |
Glaukos Corporation | 290.27 Million USD | 137.761% |
Globus Medical, Inc. | 53.11 Million USD | 306.373% |
Inspire Medical Systems, Inc. | -160.69 Million USD | 31.789% |
Integer Holdings Corporation | 1.01 Billion USD | 110.775% |
Medtronic plc | 24.76 Billion USD | 100.443% |
Myomo, Inc. | -6.27 Million USD | -1648.149% |
Nevro Corp. | 117.61 Million USD | 193.197% |
Owlet, Inc. | -1.34 Million USD | -8073.682% |
Penumbra, Inc. | 66.85 Million USD | 263.945% |
Vicarious Surgical Inc. | -37.99 Million USD | -188.521% |
Smith & Nephew plc | 2.78 Billion USD | 103.94% |
Sonendo, Inc. | 26.34 Million USD | 516.1% |
STERIS plc | 3.17 Billion USD | 103.451% |
Stryker Corporation | 10.02 Billion USD | 101.093% |
Vapotherm, Inc. | 102.66 Million USD | 206.762% |
Zimmer Biomet Holdings, Inc. | 5.57 Billion USD | 101.965% |